Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole in Major Depression
NCT00026052Phase 2Completed
- Sponsor
- National Institute of Mental Health
- Start
- Nov 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of riluzole in major depressive disorder (MDD), sponsored by National Institute of Mental Health. Started Nov 2001; status: completed.
02
Drugs
riluzole
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00026052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00026052.